Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset Meeting Abstract


Authors: Boni, V.; Drilon, A.; Deeken, J.; Garralda, E.; Chung, H.; Kinoshita, I.; Oh, D.; Patel, J.; Xu, R.; Norenberg, R.; Brega, N.; Dima, L.; Hong, D.; Berlin, J.
Abstract Title: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset
Meeting Title: ESMO 23rd World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 3
Meeting Dates: 2021 Jun 30-Jul 3
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-07-01
Start Page: S214
End Page: S215
Language: English
ACCESSION: WOS:000670004200328
DOI: 10.1016/j.annonc.2021.05.053
PROVIDER: wos
Notes: Meeting Abstract: SO-29 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon